Literature DB >> 10334107

High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP.

X Wang1, Z An, J Geller, R M Hoffman.   

Abstract

BACKGROUND: An animal model of human prostate cancer LNCaP demonstrating high rates of spontaneous metastasis from the orthotopic site after tumor implantation would be very valuable for mechanistic and drug discovery studies. We previously developed microsurgical techniques to implant histologically intact tumor tissues orthotopically in nude mice in order to develop high metastatic mouse models of human cancer.
METHODS: Intact tissue of the androgen-dependent human prostate cancer cell line, LNCaP, was implanted on the ventral lateral lobes of the prostate gland by surgical orthotopic implantation (SOI) in a series of 20 nude mice. Mice were autopsied, and histopathological examination of primary tumors and relevant organs was done to identify and quantitate micrometastasis.
RESULTS: Eighteen of 20 animals transplanted with LNCaP by SOI had tumor growth. Mean primary tumor weight in the prostate was 9.24 g at time of necropsy. Sixty-one percent of the transplanted animals had lymph node metastasis. Forty-four percent had lung metastasis. Mean survival time was 72 days, indicating a high degree of malignancy of the tumor.
CONCLUSIONS: The extensive and widespread lung metastasis as well as lymph node metastasis following orthotopic implantation of LNCaP in nude mice and the short survival time provide a high-malignancy nude model of the LNCaP human prostate tumor.

Entities:  

Mesh:

Year:  1999        PMID: 10334107     DOI: 10.1002/(sici)1097-0045(19990515)39:3<182::aid-pros6>3.0.co;2-b

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  11 in total

1.  Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.

Authors:  Arun K Nalla; Theodore F Williams; Casey P Collins; Dustin T Rae; Grant D Trobridge
Journal:  Mol Carcinog       Date:  2015-10-29       Impact factor: 4.784

2.  High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.

Authors:  N Kitamura; T Iwamura; S Taniguchi; H Yamanari; M A Kawano; K Hollingsworth; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

4.  Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.

Authors:  Christian M Zechmann; Eva C Woenne; Gunnar Brix; Nicole Radzwill; Martin Ilg; Peter Bachert; Peter Peschke; Stefan Kirsch; Hans-Ulrich Kauczor; Stefan Delorme; Wolfhard Semmler; Fabian Kiessling
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

Review 5.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

6.  Pre-clinical Orthotopic Murine Model of Human Prostate Cancer.

Authors:  Varahram Shahryari; Hannah Nip; Sharanjot Saini; Altaf A Dar; Soichiro Yamamura; Yozo Mitsui; Melissa Colden; Nathan Bucay; Laura Z Tabatabai; Kirsten Greene; Guoren Deng; Yuichiro Tanaka; Rajvir Dahiya; Shahana Majid
Journal:  J Vis Exp       Date:  2016-08-29       Impact factor: 1.355

7.  Super natural killer cells that target metastases in the tumor draining lymph nodes.

Authors:  Siddarth Chandrasekaran; Maxine F Chan; Jiahe Li; Michael R King
Journal:  Biomaterials       Date:  2015-11-02       Impact factor: 12.479

8.  Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer.

Authors:  Michelle Longmire; Nobuyuki Kosaka; Mikako Ogawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2009-03-16       Impact factor: 6.716

9.  A novel approach to identify driver genes involved in androgen-independent prostate cancer.

Authors:  Ellyn N Schinke; Victor Bii; Arun Nalla; Dustin T Rae; Laura Tedrick; Gary G Meadows; Grant D Trobridge
Journal:  Mol Cancer       Date:  2014-05-23       Impact factor: 27.401

10.  Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01.

Authors:  Kotohiko Kimura; Ru Chih C Huang
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.